Summary:
If you are caring for someone with Alzheimer's disease, please consider the ROAD clinical research study, which will determine the safety and effectiveness of the multifunctional small molecule
AD-35 in patients with mild to moderate Alzheimer’s disease (AD).
Key Eligibility Criteria
• Between 50 and 85 years of age (inclusive)
• Diagnosed with probable AD in accordance with the National Institute on Aging and Alzheimer’s Association (NIA-AA) criteria
• Mini-Mental State Examination (MMSE) score of ≥> 15 and ≥< 26 at screening and baseline
Qualified Participants May Receive:
Study-related care and medication. Compensation for time and travel may be available for patient and caregiver.